litlas
ログインアカウント作成

Timothy Iveson

1993–2024 年に発表

60
論文数
28,230
被引用数
44
h 指数
59
i10 指数

被引用数

Timothy Iveson の年別被引用数1939 年: 被引用 2 件1993 年: 被引用 1 件1994 年: 被引用 1 件1995 年: 被引用 4 件1996 年: 被引用 4 件1997 年: 被引用 1 件1998 年: 被引用 11 件1999 年: 被引用 9 件2000 年: 被引用 15 件2001 年: 被引用 35 件2002 年: 被引用 44 件2003 年: 被引用 53 件2004 年: 被引用 66 件2005 年: 被引用 87 件2006 年: 被引用 82 件2007 年: 被引用 104 件2008 年: 被引用 114 件2009 年: 被引用 102 件2010 年: 被引用 154 件2011 年: 被引用 145 件2012 年: 被引用 96 件2013 年: 被引用 157 件2014 年: 被引用 179 件2015 年: 被引用 162 件2016 年: 被引用 155 件2017 年: 被引用 178 件2018 年: 被引用 141 件2019 年: 被引用 689 件2020 年: 被引用 818 件2021 年: 被引用 804 件2022 年: 被引用 706 件2023 年: 被引用 495 件2024 年: 被引用 944 件2025 年: 被引用 407 件2026 年: 被引用 23 件1940〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,869 件、この内訳の 18.9%中国: 引用元論文 1,140 件、この内訳の 11.5%イギリス: 引用元論文 757 件、この内訳の 7.6%イタリア: 引用元論文 633 件、この内訳の 6.4%ドイツ: 引用元論文 607 件、この内訳の 6.1%日本: 引用元論文 594 件、この内訳の 6%フランス: 引用元論文 491 件、この内訳の 5%オランダ: 引用元論文 414 件、この内訳の 4.2%スペイン: 引用元論文 305 件、この内訳の 3.1%韓国: 引用元論文 296 件、この内訳の 3%カナダ: 引用元論文 243 件、この内訳の 2.4%オーストラリア: 引用元論文 201 件、この内訳の 2%
0%18.9%その他 23.8%

機関

分野

  • Medicine83.3%
  • Biochemistry, Genetics and Molecular Biology11.1%
  • Immunology and Microbiology1.6%
  • Computer Science1.5%
  • Engineering0.6%
  • Materials Science0.5%
  • その他1.4%

トピック

  • Gastric Cancer Management and Outcomes9.2%
  • Cholangiocarcinoma and Gallbladder Cancer Studies8.5%
  • Colorectal Cancer Treatments and Studies6.3%
  • Esophageal Cancer Research and Treatment4.5%
  • Gallbladder and Bile Duct Disorders4.4%
  • Pancreatic and Hepatic Oncology Research4.3%
  • その他62.8%

共著者

全論文

検索で開く
  1. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

    著者: Juan W. Valle, Harpreet Wasan, Daniel H. Palmer, David Cunningham, Alan Anthoney, Anthony Maraveyas, Srinivasan Madhusudan, Timothy Iveson, S. Hughes, Stephen P. Pereira, Sy Ha, John Bridgewater - New England Journal of Medicine 2010 被引用: 4,404

  2. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: Guillem Argilés, Josep Tabernero, Roberto Labianca, Daniel Hochhauser, Ramón Salazar, Timothy Iveson, Pierre Laurent‐Puig, Philip Quirke, Takayuki Yoshino, Julien Taı̈eb, Erika Martinelli, Dirk Arnold - Annals of Oncology 2020 被引用: 1,327

  3. Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

    著者: David Cunningham, William Allum, Sally Stenning, J N Thompson, Cornelis J.�H. van de Velde, M. Nicolson, J.H. Scarffe, F. Lofts, Stephen Falk, Timothy Iveson, David B. Smith, Ruth E. Langley, Monica Verma, Simon Weeden, Yu Jo Chua - New England Journal of Medicine 2006 被引用: 6,362

  4. Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study

    著者: Sophia J. Wagner, Daniel Reisenbüchler, Nicholas P. West, Jan Niehues, Jiefu Zhu, Sebastian Foersch, Gregory Patrick Veldhuizen, Philip Quirke, Heike I. Grabsch, Piet A. van den Brandt, Gordon Hutchins, Susan D. Richman, Tanwei Yuan, Rupert Langer, Josien C.A. Jenniskens, Kelly Offermans, Wolfram Mueller, Richard Gray, Stephen B. Gruber, Joel K. Greenson, Gad Rennert, Joseph D. Bonner, Daniel Schmolze, Jitendra Jonnagaddala, Nicholas J. Hawkins, Robyn L. Ward, Dion Morton, Michel Seymour, Laura Magill, Marta Nowak, Jennifer Hay, Viktor H. Koelzer, David N. Church, David N. Church, Enric Domingo, Joanne Edwards, Bengt Glimelius, Ismail Gögenür, Andrea Harkin, Jen Hay, Timothy Iveson, Emma Jaeger, Caroline Kelly, Rachel Kerr, Noori Maka, Hannah Morgan, Karin A. Oien, Clare Orange, Claire Palles, Campbell S.D. Roxburgh, Owen J. Sansom, Mark Saunders, Ian Tomlinson, Christian Matek, Carol Geppert, Chaolong Peng, Cheng Zhi, Xiaoming Ouyang, Jacqueline A. James, Maurice B. Loughrey, Manuel Salto‐Tellez, Hermann Brenner, Michael Hoffmeister, Daniel Truhn, Julia A. Schnabel, Melanie Boxberg, Tingying Peng, Jakob Nikolas Kather - Cancer Cell 2023 被引用: 247

  5. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

    著者: John N Primrose, Richard Fox, Daniel H. Palmer, Hassan Malik, Rajendra Prasad, Darius Mirza, Alan Anthony, Pippa Corrie, Stephen Falk, Meg Finch-Jones, Harpreet Wasan, Paul J. Ross, Lucy Wall, Jonathan Wadsley, JEFF EVANS, Deborah Stocken, Raaj Praseedom, Yuk Ting, Brian R Davidson, John P. Neoptolemos, Timothy Iveson, James Raftery, Shihua Zhu, David Cunningham, O. James Garden, Clive Stubbs, Juan W. Valle, John Bridgewater, John Primrose, RP Fox, Helen Morement, Oscar S.H. Chan, C. Rees, Ma Yt, Tamas Hickish, Stephen Falk, Meg Finch-Jones, Ian Pope, Pippa Corrie, Tom Crosby, S. Sothi, K Sharkland, Douglas Adamson, Lucy Wall, JEFF EVANS, John Dent, U. Hombaiah, Chinenye Iwuji, Alan Anthoney, John Bridgewater, David Cunningham, Roopinder Gillmore, Paul J. Ross, S. Slater, Harpreet Wasan, Jill Waters, Juan W. Valle, Daniel H. Palmer, Hafiz Malik, John P. Neoptolemos, Olusola Olusesan Faluyi, Kate Sumpter, U. Dernedde, S Maduhusudan, G. Cogill, Caroline Archer, Timothy Iveson, Jonathan Wadsley, Suzanne Darby, Mike Peterson, AA Mukhtar, JG Thorpe, Adrian C Bateman, D. Tsang, S. Cummins, L. Nolan, Éric Beaumont, Rajendra Prasad, D. Mirza, Deborah Stocken, Raaj Praseedom, Brian R Davidson, James Raftery, Shihua Zhu, James Garden, C Stubbs, Fareeda Y. Coxon - The Lancet Oncology 2019 被引用: 1,228

  6. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial

    著者: Ángela Lamarca, Daniel H. Palmer, Harpreet Wasan, Paul J. Ross, Yuk Ting, Arvind Arora, Stephen Falk, Roopinder Gillmore, Jonathan Wadsley, Kinnari Patel, Alan Anthoney, Anthony Maraveyas, Timothy Iveson, Justin S. Waters, Claire Hobbs, Safia Barber, W. David J. Ryder, John Ramage, Linda Davies, John Bridgewater, Juan W. Valle - The Lancet Oncology 2021 被引用: 749

  7. Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

    著者: Axel Grothey, Alberto Sobrero, Anthony F. Shields, Takayuki Yoshino, James Paul, Julien Taı̈eb, John Souglakos, Qian Shi, Rachel Kerr, Roberto Labianca, Jeffrey A. Meyerhardt, Déwi Vernerey, Takeharu Yamanaka, Ioannis Boukovinas, Jeffrey P. Meyers, Lindsay A. Renfro, Donna Niedzwiecki, Toshiaki Watanabe, Valter Torri, Mark Saunders, Daniel J. Sargent, Thierry André, Timothy Iveson - New England Journal of Medicine 2018 被引用: 1,126

  8. Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer

    著者: David Cunningham, Naureen Starling, Sheela Rao, Timothy Iveson, M. Nicolson, Fareeda Y. Coxon, Gary Middleton, Francis Daniel, J. Oates, A. Norman - New England Journal of Medicine 2008 被引用: 2,312

  9. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

    著者: J-Y Douillard, David Cunningham, AD Roth, Matilde Navarro, RD James, Petr Karásek, P Jandı́k, Timothy Iveson, J Carmichael, May Alakl, G. Gruia, Lucile Awad, P Rougier - The Lancet 2000 被引用: 3,279

  10. Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials

    著者: Thierry André, Jeffrey A. Meyerhardt, Timothy Iveson, Alberto Sobrero, Takayuki Yoshino, Ioannis Souglakos, Axel Grothey, Donna Niedzwiecki, Mark Saunders, Roberto Labianca, Takeharu Yamanaka, Ioannis Boukovinas, Déwi Vernerey, Jeffrey P. Meyers, Andrea Harkin, Valter Torri, Eiji Oki, Vassilis Georgoulias, Julien Taı̈eb, Anthony F. Shields, Qian Shi - The Lancet Oncology 2020 被引用: 298

  11. Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

    著者: Gary Middleton, Paul Silcocks, Trevor F. Cox, Juan W. Valle, Jonathan Wadsley, David Propper, Fareeda Y. Coxon, Paul J. Ross, Srinivasan Madhusudan, Tom Roques, David Cunningham, Stephen Falk, Nick Wadd, Mark Harrison, Pippa Corrie, Timothy Iveson, Angus Robinson, Karen McAdam, Martin Eatock, JEFF EVANS, Caroline Archer, Tamas Hickish, Angel Garcia-Alonso, M. Nicolson, William P. Steward, Alan Anthoney, William Greenhalf, Victoria Shaw, Eithne Costello, Dean J. Naisbitt, Charlotte Rawcliffe, Gemma Nanson, John P. Neoptolemos - The Lancet Oncology 2014 被引用: 374

  12. Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

    著者: Joris van de Haar, Xuhui Ma, Salo Ooft, Pim W. van der Helm, Louisa R. Hoes, Sara Mainardi, David J. Pinato, Kristi Sun, Lisa Salvatore, Giampaolo Tortora, Ina Valeria Zurlo, Silvana Leo, Riccardo Giampieri, Rossana Berardi, Fabio Gelsomino, Valeria Merz, Federica Mazzuca, Lorenzo Antonuzzo, Gerardo Rosati, Chara Stavraka, Paul J. Ross, Maria Grazia Rodriquenz, Michele Pavarana, Carlo Messina, Timothy Iveson, Federica Zoratto, Anne Thomas, Elisabetta Fenocchio, Margherita Ratti, Ilaria Depetris, Massimiliano Cergnul, Cristina Morelli, Michela Libertini, Alessandro Parisi, Michele De Tursi, N. Zanaletti, Ornella Garrone, Janet Graham, Raffaella Longarini, Stefania Gobba, Angelica Petrillo, Emiliano Tamburini, Nicla La Verde, Fausto Petrelli, Vincenzo Ricci, Lodewyk F.A. Wessels, Michele Ghidini, Alessio Cortellini, Emile E. Voest, Nicola Valeri - Nature Medicine 2023 被引用: 84

  13. Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin

    著者: Elisa Fontana, Jeff Meyers, Alberto Sobrero, Timothy Iveson, Anthony F. Shields, Julien Taieb, Takayuki Yoshino, Ioannis Souglakos, Elizabeth C. Smyth, Florian Lordick, Markus Moehler, Anne Giraut, Andrea Harkin, Roberto Labianca, Jeffrey Meyerhardt, Thierry André, Ioannis Boukovinas, Sara Lonardi, Mark Saunders, Dewi Vernerey, Eiji Oki, Vassilis Georgoulias, Irit Ben-Aharon, Qian Shi - Journal of Clinical Oncology 2021 被引用: 104

  14. JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors

    著者: Kathryn A.F. Pennel, Phimmada Hatthakarnkul, Colin S. Wood, Guang‐Yu Lian, Sara Samir Foad Al-Badran, Jean A. Quinn, Assya Legrini, Jitwadee Inthagard, Peter Alexander, Hester van Wyk, Ahmad Kurniawan, Umar Hashmi, Michael A. Gillespie, Megan L. Mills, Aula Ammar, Jennifer Hay, Ditte K. Andersen, Colin Nixon, Selma Rebus, David K. Chang, Caroline Kelly, Andrea Harkin, Janet Graham, David N. Church, Ian D. Tomlinson, Mark Saunders, Timothy Iveson, Tamsin R.M. Lannagan, René Jackstadt, Noori Maka, Paul G. Horgan, Campbell S.D. Roxburgh, Owen J. Sansom, Donald C. McMillan, Colin W. Steele, Nigel B. Jamieson, James H. Park, Antonia K. Roseweir, Joanne Edwards - Journal of Experimental & Clinical Cancer Research 2024 被引用: 45

  15. Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

    著者: Tom Waddell, Ian Chau, David Cunningham, David González de Castro, Alicia Okines, Andrew Wotherspoon, Claire Saffery, Gary Middleton, Jonathan Wadsley, David Ferry, Wasat Mansoor, Tom Crosby, Fareeda Y. Coxon, David A. Smith, Justin S. Waters, Timothy Iveson, Stephen Falk, Sarah Slater, Clare Peckitt, Yolanda Barbáchano - The Lancet Oncology 2013 被引用: 728

  16. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial

    著者: John Bridgewater, S. Pugh, Tom Maishman, Zina Eminton, J. M. MELLOR, Amy Whitehead, Louise Stanton, M Radford, Andrea Corkhill, Gareth Griffiths, Stephen Falk, Juan W. Valle, Derek O’Reilly, Ajith K. Siriwardena, Joanne Hornbuckle, Myrddin Rees, Timothy Iveson, Tamas Hickish, O. James Garden, David Cunningham, Tim Maughan, John N Primrose, Alaaeldin Shablack, Ann O’Callaghan, Anne Marie Moody, Alex Allen, A. Brewster, Alison Brown, Astrid Mayer, Brian R Davidson, Chan Ton, Charles Wilson, C. Lowdell, Charlotte Rees, Christopher Baughan, Clare Barlow, Colin Purcell, David Smith, David Tsang, Ewan Brown, Georgina Walker, Hassan Malik, Iain Cameron, Luke Nolan, Marcia Hall, Marjorie Tomlinson, Mark Hill, Mark Peterson, Meg Finch-Jones, Nagappan Kumar, N D Karanjia, Nasim Ali, Nigel Heaton, Nua Chan Ton, Paul J. Ross, Raaj Praseedom, Robert Thomas, Sally Clive, Sarah Slater, Sarah Smith, Satvinder Mudan, Satya Bhattacharya, Sharadah Essapen, Sherif Raouf, Stephen W. Fenwick, Susan Cleator, Tom Diamond, Vanessa Potter - The Lancet Oncology 2020 被引用: 239

  17. Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer

    著者: Timothy Iveson, Alberto Sobrero, Takayuki Yoshino, Ioannis Souglakos, Fang‐Shu Ou, Jeffrey P. Meyers, Qian Shi, Axel Grothey, Mark Saunders, Roberto Labianca, Takeharu Yamanaka, Ioannis Boukovinas, Niels Henrik Holländer, Fabio Galli, Kentaro Yamazaki, Vassilis Georgoulias, Rachel Kerr, Eiji Oki, Sara Lonardi, Andrea Harkin, Gerardo Rosati, James Paul - Journal of Clinical Oncology 2021 被引用: 104

  18. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial

    著者: John Primrose, Stephen Falk, Meg Finch-Jones, Juan W. Valle, Derek O’Reilly, Ajith K. Siriwardena, Joanne Hornbuckle, Mark Peterson, Myrddin Rees, Timothy Iveson, Tamas Hickish, Rachel Butler, Louise Stanton, Elizabeth Dixon, Louisa Little, Megan Bowers, S. Pugh, O. James Garden, David Cunningham, Tim Maughan, John Bridgewater - The Lancet Oncology 2014 被引用: 433

  19. 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial

    著者: Timothy Iveson, Rachel Kerr, Mark Saunders, Jim Cassidy, Niels Henrik Holländer, Josep Tabernero, Andrew Haydon, Bengt Glimelius, Andrea Harkin, Karen Allan, John McQueen, Claire Scudder, Kathleen Boyd, Andrew Briggs, Ashita Waterston, Louise Medley, Charles B. Wilson, Richard Ellis, Sharadah Essapen, A.S. Dhadda, Mark Harrison, Stephen Falk, Sherif Raouf, Charlotte Rees, Rene K Olesen, David Propper, John Bridgewater, Ashraf Azzabi, David Farrugia, Andrew Webb, David Cunningham, Tamas Hickish, Andrew Weaver, Simon Gollins, Harpreet Wasan, James Paul - The Lancet Oncology 2018 被引用: 188

  20. A new prognostic and predictive tool for shared decision making in stage III colon cancer

    著者: Alberto Sobrero, Alberto Puccini, Qian Shi, Axel Grothey, Thierry André, Anthony F. Shields, Ioannis Souglakos, Takayuki Yoshino, Timothy Iveson, Marcello Ceppi, Paolo Bruzzi - European Journal of Cancer 2020 被引用: 69

  21. NEOPRISM-CRC: Neoadjuvant pembrolizumab stratified to tumour mutation burden for high risk stage 2 or stage 3 deficient-MMR/MSI-high colorectal cancer.

    著者: Kai‐Keen Shiu, Yanrong Jiang, Mark Saunders, Jenny F. Seligmann, Timothy Iveson, Richard H. Wilson, Janet Graham, Khurum Khan, Anna-Maria Militello, Sandra Irvine, Temi Adedoyin, Rubina Begum, Reshma Bhat, William Wilson, Andrew Plumb, Austin Obichere, Manuel Rodriguez‐Justo, Marnix Jansen - Journal of Clinical Oncology 2024 被引用: 33

  22. Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials

    著者: Claire Gallois, Qian Shi, Jeffrey P. Meyers, Timothy Iveson, Steven R. Alberts, Aimery de Gramont, Alberto F. Sobrero, Daniel G. Haller, Eiji Oki, Anthony F. Shields, Richard M. Goldberg, Rachel Kerr, Sara Lonardi, Greg Yothers, Caroline Kelly, Ioannis Boukovinas, Roberto Labianca, Frank A. Sinicrope, Ioannis Souglakos, Takayuki Yoshino, Jeffrey A. Meyerhardt, Thierry André, Demetris Papamichael, Julien Taı̈eb - Journal of Clinical Oncology 2022 被引用: 50

  23. Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study

    著者: Lennard Y. W. Lee, Thomas Starkey, Maria C. Ionescu, Martin Little, Michaël Tilby, Arvind Tripathy, Hayley McKenzie, Youssra Al-Hajji, Matthew Barnard, Liza Benny, Alexander Burnett, Emma Cattell, Jackie Charman, James J. Clark, Sam Khan, Q. Ghafoor, George Illsley, Catherine Harper‐Wynne, Rosie Hattersley, Alvin Lee, Pauline Leonard, Justin K. H. Liu, Emma Kinloch, Emily Lam, Gillian Murphy, Malcolm Rhodes, Kate Robinson, Matthew Pang, Jennifer Pascoe, James R. Platt, Vanessa Potter, Amelia Randle, Anne Rigg, Tim Robinson, Tom Roques, René L. Roux, Stefan Rozmanowski, Mark Tuthill, Isabella Watts, Sarah Williams, Timothy Iveson, Siow Ming Lee, Gary Middleton, Mark R. Middleton, Andrew Protheroe, Matthew W. Fittall, Tom Fowler, Peter Johnson - The Lancet Oncology 2022 被引用: 96

  24. Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial

    著者: Nalinie Joharatnam‐Hogan, Fay Cafferty, Richard Hubner, Daniel Swinson, Sharmila Sothi, Kamalnayan Gupta, Stephen Falk, Kinnari Patel, Nicola Warner, Victoria Kunene, Sam Rowley, Komel Khabra, Tim Underwood, Janusz Jankowski, John Bridgewater, Anne Crossley, Verity Henson, Lindy Berkman, Duncan C. Gilbert, Howard Kynaston, Alistair Ring, David Cameron, Farhat V N Din, Janet Graham, Timothy Iveson, Richard Adams, Anne Thomas, Richard H. Wilson, C.S. Pramesh, Ruth E. Langley, John Burn, Sue Campbell, Lisa Capaldi, Yvonne Carse, Durga Gadgil, Arnold Goldman, Sudeep Gupta, Gregory Leonard, Mairead MacKenzie, Mahesh Parmar, Carlo Patrono, Russell Petty, Peter M. Rothwell, R. Steele - ˜The œLancet. Gastroenterology & hepatology 2019 被引用: 65